Logo
x

Search

Subscribe Now

odd

Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis

Seelos' SLS-005 (Trehalose) Receives EC's Orphan Drug Designation to Treat Amyotrophic Lateral Sclerosis

  • May 28, 2021
Vico's VO659 Receives EC's Orphan Drug Designation for Spinocerebellar Ataxia

Vico's VO659 Receives EC's Orphan Drug Designation for Spinocerebellar Ataxia

  • February 10, 2021
AbbVie's Elezanumab (ABT-555) Receives the US FDA's Orphan Drug and Fast Track Designation for Spinal Cord Injury

AbbVie's Elezanumab (ABT-555) Receives the US FDA's Orphan Drug and Fast Track Designation for Spinal Cord Injury

  • September 29, 2020
BioLineRx's Motixafortide (BL-8040) Receives EC's ODD to Treat Pancreatic Cancer in Europe

BioLineRx's Motixafortide (BL-8040) Receives EC's ODD to Treat Pancreatic Cancer in Europe

  • January 15, 2020
Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) Receives the US FDA's ODD for the Treatment of Organophosphate Exposure

Eagle Pharmaceuticals' Ryanodex (dantrolene sodium) Receives the US FDA's ODD for the Treatment of Organophosphate Exposure

  • December 17, 2019
Acceleron's ACE-083 Receives FDA's ODD for Charcot Marie Tooth Disease (CMT)

Acceleron's ACE-083 Receives FDA's ODD for Charcot Marie Tooth Disease (CMT)

  • March 6, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.